Morgan Stanley cuts Gilead price target to $163
Morgan Stanley reduced its Gilead Sciences price target to $163.00 per share from $165.00, according to Benzinga via TradingView News.
Story updates
02:44:43 PM UTC
SquawkNews
Gilead Sciences Price Target Cut to $163.00/Share From $165.00 by Morgan Stanley